ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Exosens SA

Exosens SA (EXENS)

20.07
0.00
(0.00%)
Closed January 20 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
20.07
Bid
20.04
Ask
20.30
Volume
0.00
0.00 Day's Range 0.00
16.842 52 Week Range 24.945
Previous Close
20.07
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
61,012
Financial Volume
-
VWAP
-

EXENS Latest News

Bilan semestriel du contrat de liquidité d'Exosens avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité d'Exosens avec Kepler Cheuvreux COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE – 14 JANVIER 2025 BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉD’EXOSENS AVEC KEPLER...

Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux

Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux PRESS RELEASEMÉRIGNAC, FRANCE – 14 JANUARY 2025 HALF-YEARLY REPORT ON EXOSENS’ LIQUIDITY CONTRACTWITH KEPLER CHEUVREUX...

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025...

Exosens annonce des résultats estimés annuels 2024 supérieurs aux perspectives présentées lors de l'introduction en bourse et prévoit pour 2025 une croissance de l'EBITDA ajusté dans le bas de la fourchette 20-25 %

Exosens annonce des résultats estimés annuels 2024 supérieurs aux perspectives présentées lors de l'introduction en bourse et prévoit pour 2025 une croissance de l'EBITDA ajusté dans le...

Le parlement allemand approuve la 3ème option du contrat de vision nocturne OCCAR, qui prévoit la fourniture de 25 000 jumelles équipées de tubes intensificateurs d'image Photonis

Le parlement allemand approuve la 3ème option du contrat de vision nocturne OCCAR, qui prévoit la fourniture de 25 000 jumelles équipées de tubes intensificateurs d'image Photonis LE...

German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes

German parliament approves the 3rd option of the OCCAR night vision contract under which 25 000 binoculars will be provided equipped with Photonis image intensifier tubes GERMAN PARLIAMENT...

Exosens joins the MSCI France Small Cap index

Exosens joins the MSCI France Small Cap index PRESS RELEASEMÉRIGNAC, FRANCE – 25 NOVEMBER 2024 EXOSENS JOINS THE MSCI FRANCE SMALL CAP INDEX Exosens (Ticker: EXENS – ISIN: FR001400Q9V2), a...

Exosens intègre l’indice MSCI France Small Cap

Exosens intègre l’indice MSCI France Small Cap COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE – 25 NOVEMBRE 2024 EXOSENS INTÈGRE L’INDICE MSCI FRANCE SMALL CAP Exosens (Ticker : EXENS – ISIN :...

Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras

Exosens enters into exclusive negotiations to acquire Noxant, specialized in high performance cooled infrared cameras EXOSENS ENTERS INTO EXCLUSIVE NEGOTIATIONS TO ACQUIRE NOXANT, SPECIALIZED IN...

Exosens entre en négociations exclusives en vue de l'acquisition de Noxant, spécialiste des caméras infrarouges refroidies hautes performances

Exosens entre en négociations exclusives en vue de l'acquisition de Noxant, spécialiste des caméras infrarouges refroidies hautes performances EXOSENS ENTRE EN NEGOCIATIONS EXCLUSIVES EN VUE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.935-12.758096066123.00523.119.26613998920.19728298DE
41.0145.3211586901819.05623.87518.766921720.41933186DE
120.070.352023.87516.8426101219.54569431DE
26-1.61-7.4261992619921.6823.87516.8424353019.85483166DE
52-3.93-16.3752424.94516.8426182820.86421186DE
156-3.93-16.3752424.94516.8426182820.86421186DE
260-3.93-16.3752424.94516.8426182820.86421186DE

EXENS - Frequently Asked Questions (FAQ)

What is the current Exosens share price?
The current share price of Exosens is 20.07 €
What is the 1 year trading range for Exosens share price?
Exosens has traded in the range of 16.842 € to 24.945 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCAABC Arbitrage
4.805 €
(0.00%)
0
ABAb Science
1.75 €
(0.00%)
0
AALBAalberts NV
34.20 €
(0.00%)
0
AAAAlan Allman Associates
7.35 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0
ABCAABC Arbitrage
4.805 €
(0.00%)
0
ABAb Science
1.75 €
(0.00%)
0
AALBAalberts NV
34.20 €
(0.00%)
0
AAAAlan Allman Associates
7.35 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0
ABCAABC Arbitrage
4.805 €
(0.00%)
0
ABAb Science
1.75 €
(0.00%)
0
AALBAalberts NV
34.20 €
(0.00%)
0
AAAAlan Allman Associates
7.35 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0

Discussion

View Full Feed
HomerRomer HomerRomer 10 minutes ago
Any truth to "if you put in a sell order (no matter how high of a price), the shares will be protected from being lent to shorts"?
AVXL
Steady_T Steady_T 16 minutes ago
The compassionate use program would sure sound like RWE.
NWBO
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 17 minutes ago
$TANH >>> She's ready for her big up-move, finally! ;-D

Nice Newsflow started!

Tantech Holdings Ltd. ($TANH) Subsidiary Gohomeway Group Inc. Successfully Registers EU Trademark
PR NEWSWIRE | 01/16/2025
https://www.prnewswire.com/news-releases/tantech-holdi
TANH
StockItOut StockItOut 18 minutes ago
https://www.saveboard.com.au
XERI
mrfence mrfence 19 minutes ago
ZERO $FMCC~ $FNMA~
FMCC FNMA
Lakota-45 Lakota-45 20 minutes ago
The 15% - Pre-Payment - has now been confirmed twice, and I'm assuming that
the S-1 has been filed. The S-1 has a 30 day approval, and if the SEC
doesn't respond in 30 days, . . . approval is automatic !!!

~ So Yes, . . it is very likely that both Companies will ann
INQD WDLF
SierraPacificRising SierraPacificRising 21 minutes ago
That's my boy ! Hookers and blow in Vegas my mofo. 
FNMA
BeachBum BeachBum 27 minutes ago
You said 75 mil coming off ask a few weeks ago. I know the 100 mil day volume wasn’t you.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175624344
PSRU
gitreal gitreal 29 minutes ago
Okay, you got me to go back and re-read the CMC PR. I still see only the info about the financial deal with NBRI for the mill. Nothing about the mill being fully permitted or in full operations, etc.

https://www.globenewswire.com/news-release/2025/01/15/3009809/0/en/CMC-Metals-Esta
CMC NBRI
StockItOut StockItOut 30 minutes ago
No end of story! Biza had a Xeriant Europe company before Duffy n Crew took Banjo & Matilda to change name to Xeriant, Inc., where then Xeriant, Inc. partnered with Xeriant Europe s.r.o. which had the name well prior.
XERI
mascale mascale 30 minutes ago
Comparing, only waterchaser poster knows the names of persons in outsourced former contactor offices(?).
HIRU
bwrbad bwrbad 33 minutes ago
bandwagon
RXRX
TightCoil TightCoil 36 minutes ago
Yes, We should sail,
Hoist The Main Sail
Hoist the Spinnaker
Catch Some Wind
FNMA
mascale mascale 38 minutes ago
The illiterate contrary posters fail to notice over $13.0 mil. cash in Q3 report and completion of successful Regulation S stock sales in 12/9 report--". . .we are proud to share that we have successfully secured partnerships with offshore investors through a Regulation S offering." Now Tasmanian mi
HIRU
TightCoil TightCoil 39 minutes ago
Reparations and Re-Listing on Big Board
Sing It Out - Shout It Out
Reparations and Re-Listing - Sing It
Reparations and Re-Listing - Shout It
FNMA
joeycav11 joeycav11 39 minutes ago
My take away from new regulations allowing MHRA use of real world evidence is that the data collected from treatments other types of cancer that used DC Vax via the compassionate care program can be used for submission of approvals for these new indications.
NWBO
Top Penny Top Penny 40 minutes ago
Probably picking up 20 million this coming week
PSRU
WiseYoda WiseYoda 42 minutes ago
Classic head fake….XRP will change direction once it finishes its course. Watch how it will change as were moving sideways now.
XRPUSD
jeunke22 jeunke22 42 minutes ago
Now that everybody received acknowledgment of their issues and frustrations with management , bonuses and perceived or real operational issues, can we go forward and concentrate at the huge opportunity in a civilized way?
The technology is real, the market is huge, new leadership is meant t
LWLG
Jack Torrance Jack Torrance 43 minutes ago
And I submit these documents through the "evidence" submittal part of the website?
ENZC
wadegarret wadegarret 44 minutes ago
COHR. CRMD, GERN, AESI, FEIM

A good 5 stocker. Two small caps. and three mid caps. GERN makes no money, but a bet on a drug that only has one competitor in the entire world to treat a deadly anemia. All 5 are good values imo
COHR CRMD GERN
TightCoil TightCoil 46 minutes ago
Your language/words are uncannily
similar to Rick Nagra. Say it isn't so.
FNMA
Truenorth2016 Truenorth2016 48 minutes ago
Looking forward to the next GCAN PR. Looking at other stocks with really good news and not running makes me believe there is no more teamwork left in the OTC. Been here on this board since 2015 and it feels like someone died coming to this platform. I mean most traders either changed their names or
GCAN

Your Recent History

Delayed Upgrade Clock